Number of Shares
-
Current Holdings Value*
N/A
% of Portfolio
0%
Total Estimate Gain
$14.87 Mil
% of Total Estimate Gain
189.70%

SAMSARA BIOCAPITAL, LLC's Aclaris Therapeutics Inc Holding Summary

As of 2025-03-31, SAMSARA BIOCAPITAL, LLC held - shares of Aclaris Therapeutics Inc(ACRS), totaling N/A. This investment constitutes 0% of their stock portfolio, and SAMSARA BIOCAPITAL, LLC now holds 0% of the outstanding Aclaris Therapeutics Inc(ACRS) stock.

The initial trade took place in 2020Q1. And since then SAMSARA BIOCAPITAL, LLC has made 2 purchases of ACRS, at an average price of $1.82, for a total of 4.30 Mil shares. In addition, there have been 6 sales at an average price of $5.28 for 4.30 Mil shares. Based on historical transaction data and ACRS's current price of $1.57, SAMSARA BIOCAPITAL, LLC's estimated gain on his ACRS holdings is $14.87 Mil, reflecting a 189.70% gain to date.

SAMSARA BIOCAPITAL, LLC ACRS ($1.57) Holding Chart

SAMSARA BIOCAPITAL, LLC ACRS ($1.57) Quarterly Buys and Sells

Period Bought/Sold (Sh.) % Change Qtr. End Shares Avrg. Price
Shares Bought 0 Average Price $-/Share
Shares Sold 0 Average Price $-/Share
Current Price $0.00 Total Estimated Gain 0 %

Top Ranked Articles

  • 1